Navigation Links
One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
Date:9/21/2007

en compared to insulin glargine, as well as improved beta-cell function that has only been associated with exenatide treatment," said Michaela Diamant, M.D., Ph.D., Associate Professor of Endocrinology, Department of Endocrinology, VU University Medical Center, Amsterdam, The Netherlands, and an author of the study. "This study lends further support to past findings and showed that adding exenatide significantly improved beta-cell function as measured by both glucose and arginine induced insulin secretion."

The side effects associated with exenatide treatment were consistent with those seen in previous studies. In clinical trials, the most common side effect is nausea, most of which is mild to moderate, affecting approximately half of patients and usually decreasing over time. Exenatide-treated patients had a lower incidence of hypoglycemia compared to insulin glargine-treated patients (8.3 percent vs. 24.2 percent, respectively).

About BYETTA(R) (exenatide) injection

BYETTA is the first in a class of drugs called incretin mimetics for the treatment of type 2 diabetes. BYETTA exhibits many of the same effects as the human incretin hormone glucagon like peptide-1 (GLP-1). GLP-1 improves blood sugar after food intake through multiple effects that work in concert on the stomach, liver, pancreas and brain. BYETTA is approved by the U.S. Food and Drug Administration ("FDA") for use by people with type 2 diabetes who are unsuccessful at controlling their blood sugar levels. BYETTA is an add-on therapy for people currently using metformin, a sulfonylurea, or a thiazolidinedione. For full prescribing information, visit http://www.BYETTA.com.

About Incretin Mimetics

Incretin mimetics are a distinct class of agents used to treat diabetes. An incretin mimetic works to mimic the anti-diabetic or glucose-lowering actions of naturally occurring human hormones called incretins. These actions include st
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 2013 China Biologic Products, Inc. (Nasdaq: CBPO, ... plasma-based biopharmaceutical company in China , ... a public announcement issued by Shanghai RAAS Blood Products ... Shenzhen Stock Exchange, that on May 21, 2013, Ms. ... one of the shareholders of the Company, and her ...
(Date:5/24/2013)... GARDEN CITY, England and BOSTON ... the leading GPCR drug discovery and development company, is pleased to ... as a Consultant to augment the Company,s business development capabilities ... Mr Usui has more than 15 years of experience in ... senior roles at Perlegen Sciences, Inc., Roche Pharma ( Japan ...
(Date:5/23/2013)... 23, 2013 Amgen (NASDAQ: AMGN ) ... Healthcare Conference on Thursday, May 30, 2013, at the Westin ... 9:20 a.m. Eastern Daylight Time. Arvind Sood ... at the conference. Live audio of the presentation can be ... , under Investors. A replay of the webcast will also ...
Breaking Medicine Technology:China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2
... SAN DIEGO, April 26, 2011 Cadence ... company focused on in-licensing, developing and commercializing proprietary products ... that the company,s President and CEO Theodore Schroeder will ... during the month of May: Deutsche ...
... 2011 Rochester Medical Corporation (NASDAQ: ROCM ) ... May 5, 2011.  The Company will then hold a quarterly ... begin at 3:30 p.m. central time (4:30 p.m. eastern time). ... can be accessed at Rochester Medical,s website at www.rocm.com ...
Cached Medicine Technology:Rochester Medical Announces Second Quarter 2011 Earnings Conference Call Thursday, May 5, 2011 2
(Date:5/24/2013)... In a coup that surely made other Palm ... the Estetica Institute of the Palm Beaches performed eye surgeries ... morning show, “The Mo & Sally Morning Show.” The DJ’s ... with the results, giving Dr. DeLange and the team at ... Gardens, very valuable free publicity. , Dr. DeLange, the owner ...
(Date:5/24/2013)... FL (PRWEB) May 24, 2013 The producers ... May air dates for Charlotte, North Carolina. It is one ... many Fortune 500 companies. The city is populated with more ... organizations which cover residents in both North and South Carolina. ... all things medically-related can tune into WAXN-TV 64 Eyewitness News ...
(Date:5/24/2013)... 24, 2013 Fit Yummy Mummy, a ... mothers who are trying to get rid of the ... is ideal for women who want to combine exercises ... ’s Stan Stevenson, prompting an investigative review. , ... contains a wide variety of motivational strategies, nutritional plans, ...
(Date:5/24/2013)... GA (PRWEB) May 24, 2013 CBT News.com ... Sales. Gonter joins the web-based retail automotive industry news organization ... , “I’m excited to join a group that’s so ... perfect example of how online video content is on the ... in the motorcycle business and segued into advertising at Cycle ...
(Date:5/24/2013)... Residents of San Diego have a new ... expert, and Certified Russian Kettlebell Instructor, Cody Bramlett has ... San Diego, California. The classes take place Monday through ... Initial sign-ups are available online and by clicking ... for years. The bootcamps being offered in San ...
Breaking Medicine News(10 mins):Health News:Dr. Greg DeLange of the Estetica Institute Recently Performed Eye Surgery on Both Members of Popular Morning Radio Team 2Health News:Health Briefs TV Presents May Air Dates for Charlotte, North Carolina 2Health News:Fit Yummy Mummy: Review Examining Holly Rigsby’s Fitness Program Released 2
... regulation of body weight suggests a potential mechanism underlying ... of two competing hypotheses of weight regulation. In ... General Hospital (MGH) investigators outline a system in which ... animal,s weight tends to gravitate, rather than a single ...
... R. Hill has been appointed,Interim President and CEO of ... to accept a position as president of HealthAmerica,s,Central Pennsylvania ... ) , Hill,s selection ... board of directors. , "The ...
... who allegedly was seriously injured by Medtronic, Inc.,s Infuse(R) ... by Medtronic has sued the company, according to James ... LLC.The firms, along with co-counsel Lieff, Cabraser, Heimann & ... on behalf of Paul and Susan Antonelli, of Amsterdam, ...
... too different from others , , WEDNESDAY, Jan. 14 ... go along with popular opinion in social situations, a ... resonance imaging showed that people whose opinion differed with ... response in the brain,s rostral cingulate zone (RCZ) and ...
... National Cancer Coalition (NCC) and Wyeth Pharmaceuticals (Wyeth) ... assist cancer patients in Latin America with donations ... injection) and Neumega(TM) (oprelvekin). United States Ambassador Michael ... a hand-over event held at the Instituto Nacional ...
... oust reformers, local union officers unopposedOAKLAND, Calif., Jan. ... Rosselli and all 17 other statewide officers were ... chair Debby Schneider. Their victory comes despite a ... to oust reformers in the local union from ...
Cached Medicine News:Health News:New model system may better explain regulation of body weight 2Health News:New model system may better explain regulation of body weight 3Health News:HealthPlus Names Bruce Hill Interim President and CEO 2Health News:Medtronic, Inc. and Medtronic Sofamor Danek USA, Inc. Sued for Product Liability and Promoting the Off-Label Use of Infuse(R) Bone Graft Product, According to Page Perry, LLC 2Health News:NCC and Wyeth Donation to Assist Cancer Patients in Latin America 2Health News:United Healthcare Workers Re-Elect All Statewide Officers 2
... evaluation of pancreatic -cell function is not only ... of the natural history of diabetes mellitus, but ... guide to the correct choice of treatment. Peripheral ... function because of the large and variable uptake ...
... for the control of glucose metabolism. It ... of Langerhans as the precursor, proinsulin, which is ... are secreted in equimolar amounts into the portal ... of two polypeptide chains, the A-chain and B-chain ...
ENA Screen EIA Auto-Immune Markers 012-MDKES1 Extractable Nuclear Antigens...
Anti-PR3 EIA Auto-Immune Markers 013-PR3-48 Proteinase...
Medicine Products: